PATENT CLAIM ANALYSIS

Application Number: 15768388
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "300000"]

Abstract:
The present invention relates to a compound of the following general formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, for use as inhibitor of cellular necroptosis. The present invention also relates to a pharmaceutical composition comprising a compound of general formula (I), or a pharmaceutically acceptable salt and/or solvate thereof, for use for preventing and/or treating disorders associated with cellular necroptosis. The present invention also encompasses the use of a compound of the general formula (I) for organs preservation.

Claim (Index 6):
The method according to  claim 11 , wherein R 3 , R 5  and R 6  are H.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 91.0
- Lexical Diversity: 2.21429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15768395', '12086792', '15100967', '11998817', '14703004']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7986473830720768
- 35 USC 102 Novelty (BERT): 0.5814884978855234
- Combined Prediction Score: 0.7769314945534216
- Mean Citation Score: 388.673318
- Max Citation Score: 647.97546
- Similarity Product: 365.7470613939643

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test